Clinical trials
Completed Phase 1/2 Neuroblastoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2003 | 2 |
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Duke University | 2 |
| Fred Hutchinson Cancer Center | 2 |
| Novartis Pharmaceuticals | 2 |
| Baylor College of Medicine | 1 |
| Cancer Research UK | 1 |
| Celgene | 1 |
| Children's Oncology Group | 1 |
| Eli Lilly and Company | 1 |
| Genzyme, a Sanofi Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroblastoma | 25 |
| Rhabdomyosarcoma | 8 |
| Medulloblastoma | 6 |
| Lymphoma | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Sarcoma | 5 |
| Burkitt Lymphoma | 4 |
| Hodgkin Disease | 4 |
| Leukemia | 4 |
| Leukemia, Myeloid, Acute | 4 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.